The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

Alan Pollack*, Theodore G. Karrison, Alexander G. Balogh, Leonard G. Gomella, Daniel A. Low, Deborah W. Bruner, Jeffrey S. Wefel, Andre Guy Martin, Jeff M. Michalski, Steve J. Angyalfi, Himanshu Lukka, Sergio L. Faria, George B. Rodrigues, Marie Claude Beauchemin, R. Jeffrey Lee, Samantha A. Seaward, Aaron M. Allen, Drew C. Monitto, Wendy Seiferheld, Oliver SartorFelix Feng, Howard M. Sandler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences